B+
Bull case
25%
Probability
Target price
$3.00
Analysis reference price unavailable
Analysis 2026-09-12 · RankAlpha Sentiment Codex
MDAI
Spectral AICNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
FDA clearance has removed a major regulatory barrier, while planned U.S. sales, international authorization, and a clinical-outcomes study provide several potential validation points.
Posture
Mixed
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
A $14.0 million cash balance must support commercialization and ongoing development; the additional $6.5 million credit-facility draw introduces leverage and potential future financing or dilution risk [#SEC-8K-2026-08-12].
Momentum
72
Value
37
Sentiment
61
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.75 · Bull $3.00 · Bear $0.75Analysis 2026-09-12; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-11 • Model: HYBRID_IC_RP
AI Memo
As of 2026-09-12 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-11
Investment thesis
As of 2026-09-11
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-11. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $5.13
Why
Momentum72 · Δ7d -
Value37 · Δ7d -0.0
Sentiment61 · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Confirming evidence
- • Sentiment remains the lead driver in the composite.
Contradictions & invalidation
- • A $14.0 million cash balance must support commercialization and ongoing development; the additional $6.5 million credit-facility draw introduces leverage and potential future financing or dilution risk [#SEC-8K-2026-08-12].
- • DeepView has regulatory authorization, but initial U.S. commercial demand and hospital procurement timing have not yet been demonstrated.
- • Commercial demand, procurement duration, pricing, and recurring economics remain unproven.
Catalyst clock
2026-12-31
UKCA label expansion decision
Lead driver: Sentiment · See AI snapshot
Momentum
72
9% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
37
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.2
Sentiment
61
62% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade C. Momentum 72.1 / Value 36.6 / Sentiment 60.9
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-09-12. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$1.75
Analysis reference price unavailable
Analysis 2026-09-12 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$0.75
Analysis reference price unavailable
Analysis 2026-09-12 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$52.78M
Beta
0.94
Shares Out
32.18M
P/E (TTM) · Derived
-5.7
P/S (TTM)
2.11
P/FCF (TTM) · Derived
-3.87
Rev YoY
-30.4%
EPS YoY
-58.5%
Gross Margin
+41.5%
Op Margin
-79.9%
Net Debt
-$5.3M
Current Ratio
0.90
As of 2026-09-11 • Updated nightlySource: Internal modelMethods & Data